Difference between revisions of "Template:Acetylcholine receptor modulators"
Jump to navigation
Jump to search
sr:Шаблон:Холинергици
blackwiki>Medgirl131 |
blackwiki>Medgirl131 |
||
| Line 4: | Line 4: | ||
| state = {{{state<includeonly>|collapsed</includeonly>}}} | | state = {{{state<includeonly>|collapsed</includeonly>}}} | ||
| listclass = hlist | | listclass = hlist | ||
| − | |||
| selected = {{{selected|{{{1|}}}}}} | | selected = {{{selected|{{{1|}}}}}} | ||
| + | | groupstyle = text-align:center; | ||
| − | | section1 = [[Acetylcholine receptor|Receptor]] [[ | + | | section1 = [[Acetylcholine receptor|Receptor]] [[receptor modulator|modulator]]s |
| abbr1 = Receptor | | abbr1 = Receptor | ||
| state1 = uncollapsed | | state1 = uncollapsed | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
| + | | groupstyle = text-align:center; | ||
| group1 = [[Muscarinic acetylcholine receptor|mACh]] | | group1 = [[Muscarinic acetylcholine receptor|mACh]] | ||
| list1 = | | list1 = | ||
| − | * ''' | + | * '''Agonists:''' [[77-LH-28-1]] |
* [[AC-42]] | * [[AC-42]] | ||
* [[AC-260,584]] | * [[AC-260,584]] | ||
| Line 69: | Line 70: | ||
* [[YM-796]] | * [[YM-796]] | ||
| − | * ''' | + | * '''Antagonists:''' [[3-Quinuclidinyl benzilate]] |
* [[1,1-Dimethyl-4-diphenylacetoxypiperidinium iodide|4-DAMP]] | * [[1,1-Dimethyl-4-diphenylacetoxypiperidinium iodide|4-DAMP]] | ||
* [[Aclidinium bromide]] | * [[Aclidinium bromide]] | ||
| Line 163: | Line 164: | ||
| group2 = [[Nicotinic acetylcholine receptor|nACh]] | | group2 = [[Nicotinic acetylcholine receptor|nACh]] | ||
| list2 = | | list2 = | ||
| − | * ''' | + | * '''Agonists:''' [[5-Hydroxyindoleacetic acid|5-HIAA]] |
* [[A-84,543]] | * [[A-84,543]] | ||
* [[A-366,833]] | * [[A-366,833]] | ||
| Line 232: | Line 233: | ||
* [[XY-4083]] | * [[XY-4083]] | ||
| − | * ''' | + | * '''Antagonists:''' [[18-Methylaminocoronaridine|18-MAC]] |
* [[18-Methoxycoronaridine|18-MC]] | * [[18-Methoxycoronaridine|18-MC]] | ||
* [[α-Neurotoxin]]s (e.g., [[α-bungarotoxin]], [[α-cobratoxin]], [[α-conotoxin]], many others) | * [[α-Neurotoxin]]s (e.g., [[α-bungarotoxin]], [[α-cobratoxin]], [[α-conotoxin]], many others) | ||
| Line 321: | Line 322: | ||
}} | }} | ||
| − | | section2 = [[Neurotransmitter transporter|Transporter]] [[ | + | | section2 = [[Neurotransmitter transporter|Transporter]] [[transporter modulator|modulator]]s |
| abbr2 = Transporter | | abbr2 = Transporter | ||
| state2 = uncollapsed | | state2 = uncollapsed | ||
| list2 = {{Navbox|child | | list2 = {{Navbox|child | ||
| + | | groupstyle = text-align:center; | ||
| group1 = [[Choline transporter|CHT]] | | group1 = [[Choline transporter|CHT]] | ||
| Line 330: | Line 332: | ||
* '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]] | * '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]] | ||
* [[Triethylcholine]] | * [[Triethylcholine]] | ||
| + | |||
* '''Enhancers:''' [[Coluracetam]] | * '''Enhancers:''' [[Coluracetam]] | ||
| Line 342: | Line 345: | ||
| state3 = uncollapsed | | state3 = uncollapsed | ||
| list3 = {{Navbox|child | | list3 = {{Navbox|child | ||
| + | | groupstyle = text-align:center; | ||
| group1 = [[Choline acetyltransferase|ChAT]] | | group1 = [[Choline acetyltransferase|ChAT]] | ||
| Line 473: | Line 477: | ||
* [[Fasciculin|Fasciculins (green mamba toxins)]] ([[Fasciculin 1|1]], [[Fasciculin 2|2]], [[Fasciculin 3|3]], [[Fasciculin 4|4]]) | * [[Fasciculin|Fasciculins (green mamba toxins)]] ([[Fasciculin 1|1]], [[Fasciculin 2|2]], [[Fasciculin 3|3]], [[Fasciculin 4|4]]) | ||
* [[Onchidal]] (''[[Onchidella binneyi]]'') | * [[Onchidal]] (''[[Onchidella binneyi]]'') | ||
| + | |||
* '''Reactivators:''' [[Asoxime]] | * '''Reactivators:''' [[Asoxime]] | ||
* [[Obidoxime]] | * [[Obidoxime]] | ||
| Line 488: | Line 493: | ||
| state4 = uncollapsed | | state4 = uncollapsed | ||
| list4 = {{Navbox|child | | list4 = {{Navbox|child | ||
| + | | groupstyle = text-align:center; | ||
| group1 = [[Release inhibitor|Inhibitors]] | | group1 = [[Release inhibitor|Inhibitors]] | ||
| Line 507: | Line 513: | ||
| state5 = uncollapsed | | state5 = uncollapsed | ||
| list5 = {{Navbox|child | | list5 = {{Navbox|child | ||
| + | | groupstyle = text-align:center; | ||
| group1 = [[Precursor (chemistry)|Precursors]] /<br />[[prodrug]]s | | group1 = [[Precursor (chemistry)|Precursors]] /<br />[[prodrug]]s | ||
Revision as of 14:53, 29 April 2017
50px Template documentation
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Acetylcholine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Acetylcholine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Acetylcholine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.
How to manage this template's collapsible groups/sections option
- This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter
|namewhere name is one of the following words that identify the groups/sections (omit any speech or quotation marks): - Receptor
- Transporter
- Inhibitors
- Others
- For example:
{{Acetylcholine receptor modulators |Receptor}}
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |